https://www.selleckchem.com/pr....oducts/s-2-hydroxysu
istula repair. A scoping review assessed access to medications for opioid use disorder (MOUD) and treatment outcomes among adolescents (12-17 years) and young adults (18-25 years). Studies addressing adolescent and young adult opioid use disorder and treatment with MOUD on patient outcomes (eg, retention in care) were included. Randomized trials and controlled observational studies were prioritized. Investigators extracted key information, summarized findings, noted methodological weaknesses, and tabled the details. The
Like
Comment
Share
